Progression-free survival and anti-idiotype immune responses. Progression-free survival in patients with upfront idiotype vaccination (group A) and idiotype vaccination as remission consolidation (group B) according to the development of cellular (left) or humoral immune responses (right). HR indicates hazard ratio.